Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Product Profiles / 2019 / Cepheid’s molecular test determines ER/PR/HER2/Ki-67 with less variable results compared to IHC/FISH

Cepheid’s molecular test determines ER/PR/HER2/Ki-67 with less variable results compared to IHC/FISH

Cepheid’s molecular test determines ER/PR/HER2/Ki-67 with less variable results compared to IHC/FISH

Xpert® Breast Cancer STRAT41 delivers:

  • Clear molecular breast cancer biomarker results without equivocation 

  • Results in less than 2 hours to empower Oncologists

  • Four mRNA biomarkers from one unstained section for a streamlined workflow 

  • Easy to perform and train, enables efficient implementation and operation 

  • Elimination of observer variability by a standardized method with an easy to interpret and objective result report 

  • Three controls per test deliver dependable results

  • High concordance with IHC/FISH 

  • Random access and flexibility in conjunction with the GeneXpert® System 24/7


More information

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Explore Pathology Infectious Disease

The Viral Frontier

January 23, 2024

1 min read

Explore Pathology Genetics and epigenetics

Breathing New Life into Diagnostics

January 22, 2024

6 min read

Explore Pathology Analytical science

Opening a Window into Brain Trauma

January 18, 2024

4 min read

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Thank you for reading The Pathologist

To continue reading, either register for a free account below or login.

Register or Login

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.